Skip to main content
Log in

Application of population analysis to physiological pharmacokinetics

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. M. Gibaldi and D. Perrier, “Pharmacokinetics,” (2nd ed.), Dekker, New York, pp 355–384, (1982).

    Google Scholar 

  2. K.J. Himmelstein and R.J. Lutz, A review of the applications of physiologically based pharmacokinetic modeling,J. Pharmacokinet. Biopharm. 7:127 (1979).

    Article  CAS  PubMed  Google Scholar 

  3. J.F. Young and F.F. Kadlubar, A pharmacokinetic model to predict exposure of the bladder epithelium to urinary N-hydroxylarylamine carcinogens as a function of urine pH, voiding interval, and resorption.Drug Metab. Dispos. 10:641 (1982).

    CAS  PubMed  Google Scholar 

  4. R.L. Dedrick, Animal scale-up,J. Pharmacokinet. Biopharm. 1:435 (1973).

    Article  CAS  PubMed  Google Scholar 

  5. R.K. Jain, L.E. Gerlowski, J.M. Weissbrod, J. Wang, and R.N. Pierson, Kinetics of uptake, distribution and excretion of zinc in rats,Ann. Biomed. Eng. 9:347 (1981).

    Article  CAS  Google Scholar 

  6. M.J. Angelo, K.B. Bischoff, A.B. Pritchard, and M.A. Presser, A physiological model for the pharmacokinetic s of methylene chloride in B6C3F1 mice following IV administration,J. Pharmacokinet. Biopharm. 12:413 (1984).

    Article  CAS  PubMed  Google Scholar 

  7. J. Gabrielsson, L. Paalzow, and L. Nordstrom, A physiologically based pharmacokinetic model for theophylline disposition in the pregnant and nonpregnant rat,J. Pharmacokinet. Biopharm. 12:149 (1984).

    Article  CAS  PubMed  Google Scholar 

  8. J.L. Gabrielsson, P. Johansson, U. Bondesson, and L. Paalzow, Analysis of methadone disposition in the pregnant rat by means of a physiological flow model,J. Pharmacokinet. Biopharm. 13:355 (1985).

    Article  CAS  PubMed  Google Scholar 

  9. H. Harashima, Y. Sawada, Y. Sugiyama, T. Iga, and M. Hanano, Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics,J. Pharmacokinet. Biopharm. 13:425 (1985).

    Article  CAS  PubMed  Google Scholar 

  10. F.G. King, R.L. Dedrick, and F.F. Farris, Physiological pharmacokinetic modeling of cis-dichlorodiammine-platinum (II) (DDP) in several species,J. Pharmacokinet. Biopharm. 14:131 (1986).

    Article  CAS  PubMed  Google Scholar 

  11. F.G. King and R.L. Dedrick, Physiologic model for the pharmacokinetics of 2′ deoxycoformycin in normal and leukemic mice,J. Pharmacokinet. Biopharm. 9:519 (1981).

    Article  CAS  PubMed  Google Scholar 

  12. F.T. Lindstrom and D.S. Birkes, Estimation of population pharmacokinetic parameters using destructively obtained experimental data: A simulation study of the one-compartment model,Drug Metab. Dispos. 15:195 (1984).

    Article  CAS  Google Scholar 

  13. M.E. Andersen, A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: analysis at steady-state,Toxicol. Appl. Pharmacol. 60:509 (1981).

    Article  CAS  PubMed  Google Scholar 

  14. K.C. Ng, Contributions to the computation of the matrix exponential, Report 212 of the Center for Pure and Applied Mathematics, University of California, Berkeley (1984).

    Google Scholar 

  15. B.N. Parlett, A recurrence among the elements of functions of triangular matrices,Lin. Alg. Appl. 14:117 (1976).

    Article  Google Scholar 

  16. A.E. Adolph, Quantitative relations in the physiological constitutions of mammals,Science 109:579 (1949).

    Article  CAS  PubMed  Google Scholar 

  17. P.L. Altman and D.S. Dittmer, Table of Physiologic Constants, in: “Biology Data Handbook, Vol. 3,” Federation of American Societies for Experimental Biology, Bethesda, MD, pp. 1584, (1974).

    Google Scholar 

  18. C.M. Metzler, G.L. Elfring, and A.J. McEwen, “A User's Manual for NONLIN and Associated Programs,” The Upjohn Co., Kalamazoo, MI (1974).

    Google Scholar 

  19. S.R.B. Allerheiligen, T.M. Ludden, and R.F. Burk, The pharmacokinetics of pentane, a by-product of lipid peroxidation.Drug Metab. Dispos. 15:794 (1987).

    CAS  PubMed  Google Scholar 

  20. S.R.B. Allerheiligen, T.M. Ludden, and R.F. Burk, Effect of clearance on the relationship between pulmonary excretion rate andin vivo production rate of volatile substances, in: “Simulation at the Frontiers of Science,” J. Young, V.W. Ingalls, and R. Hawkins, eds. Society for Computer Simulation, San Diego, p. 49, (1986).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ludden, T.M., Allerheiligen, S.R.B. & Burk, R.F. Application of population analysis to physiological pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 19 (Suppl 3), S101–S113 (1991). https://doi.org/10.1007/BF01371012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01371012

Keywords

Navigation